Paraneoplastic movement disorders

Current Neurology and Neuroscience Reports

Volumn 9, Issue 4, 2009, Pages 285-291

  Mehta, Shyamal H ^a   Morgan, John C ^b   Sethi, Kapil D ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIPHYSIN ANTIBODY; ANTIBODY; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CORTICOTROPIN; CYCLOPHOSPHAMIDE; DIAZEPAM; HU ANTIBODY; IMMUNOGLOBULIN; LEVODOPA; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1 ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2 ANTIBODY; PREDNISONE; RECEPTOR ANTIBODY; RITUXIMAB; STEROID; TR ANTIBODY; UNCLASSIFIED DRUG; YO ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANTIBODY TITER; ATAXIA; BREAST CARCINOMA; CEREBELLUM CORTEX; CEREBELLUM DEGENERATION; CEREBELLUM NUCLEUS; CHOREA; CLINICAL TRIAL; DRUG MEGADOSE; ENCEPHALITIS; HODGKIN DISEASE; HUMAN; INFLAMMATORY INFILTRATE; LUNG CANCER; MOTOR DYSFUNCTION; NEUROBLASTOMA; NEUROLOGIC DISEASE; NEUROPATHOLOGY; OPSOCLONUS MYOCLONUS SYNDROME; OVARY TERATOMA; PARANEOPLASTIC MOVEMENT DISORDER; PARANEOPLASTIC NEUROPATHY; PARANEOPLASTIC SYNDROME; PARKINSON DISEASE; PARKINSONISM; REVIEW; STIFF MAN SYNDROME; SUPERIOR OLIVARY NUCLEUS; TESTIS TERATOMA; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR; WALKING DIFFICULTY; FEMALE; IMMUNOLOGY; MALE; PATHOPHYSIOLOGY; SEX DIFFERENCE;

ATAXIA; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CHOREA; FEMALE; HUMANS; MALE; MOVEMENT DISORDERS; OPSOCLONUS-MYOCLONUS SYNDROME; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PARKINSONIAN DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE; SEX FACTORS; TREMOR;

EID: 67651212140     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-009-0043-4     Document Type: Review

References (51)

1. Poser JB: Paraneoplastic syndromes. Rev Neurol (Paris) 2002, 158:899-906.
2. Darnell RB, Posner JB: Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003, 349:1543-1554.
3. Honnorat J, Antoine JC: Paraneoplastic neurological syndromes. Orphanet J Rare Dis 2007, 2:22.
4. Drlicek M, Bianchi G, Bogliun G, et al.: Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: A long-term survey of ovarian cancer patients. J Neurol 1997, 244:85-89.
5. Graus F, Delattre JY, Antoine JC, et al.: Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004, 75:1135-1140.
6. Dalmau J, Gonzalez RG, Lerwill MF: Case records of the Massachusetts General Hospital. Case 4-2007. A 56-year-old woman with rapidly progressive vertigo and ataxia. N Engl J Med 2007, 356:612-620.
7. Dalmau J, Rosenfeld MR: Paraneoplastic syndromes of the CNS. Lancet Neurol 2008, 7:327-340.
8. Aye MM, Kasai T, Tashiro Y, et al.: CD8 positive T-cell infiltration in the dentate nucleus of paraneoplastic cerebellar degeneration. J Neuroimmunol 2009, 208:136-140.
9. Toothaker TB, Rubin M: ParaneoplaAtic neurological syndromes: a review. Neurologist 2009, 15:21-33.
10. Phuphanich S, Brock C: Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody. J Neurooncol 2007, 81:67-69.
11. Widdess-Walsh P, Tavee JO, Schuele S, Stevens GH: Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: Case report and review of the literature. J Neurooncol 2003, 63:187-190.
12. Bernal F, Shams'ili S, Rojas I, et al.: Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 2003, 60:230-234.
13. Shams'ili S, Grefkens J, de Leeuw B, et al.: Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: Analysis of 50 patients. Brain 2003, 126(Pt 6): 1409-1418.
14. Honnorat J, Cartalat-Carel S, Ricard D, et al.: Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. J Neurol Neurosurg Psychiatry 2009, 80:412-416.
15. Esposito M, Penza P, Orefice G, et al.: Successful treatment of paraneoplastic cerebellar degeneration with rituximab. J Neurooncol 2008, 86:363-364.
16. Kraemer M, Berlit P: Progressive encephalomyelitis with rigidity and myoclonus in an 81-year-old patient. Clin Neurol Neurosurg 2008, 110:279-281.
17. De Camilli P, Thomas A, Cofiell R, et al.: The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer. J Exp Med 1993, 178:2219-2223.
18. Murinson BB, Guarnaccia JB: Stiff-person syndrome with amphiphysin antibodies: Distinctive features of a rare disease. Neurology 2008, 71:1955-1958.
19. Nguyen-Huu BK, Urban PP, Schreckenberger M, et al.: Antiamphiphysin-positive stiff-person syndrome associated with small cell lung cancer. Mov Disord 2006, 21:1285-1287.
20. McHugh JC, Murray B, Renganathan R, et al.: GAD antibody positive paraneoplastic stiff person syndrome in a patient with renal cell carcinoma. Mov Disord 2007, 22:1343-1346.
21. McCabe DJ, Turner NC, Chao D, et al.: Paraneoplastic "stiff person syndrome" with metastatic adenocarcinoma and anti-Ri antibodies. Neurology 2004, 62:1402-1404.
22. Butler MH, Hayashi A, Ohkoshi N, et al.: Autoimmunity to gephyrin in stiff-man syndrome. Neuron 2000, 26:307-312.
23. Tate ED, Allison TJ, Pranzatelli MR, Verhulst SJ: Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome. J Pediatr Oncol Nurs 2005, 22:8-19.
24. Kirsten A, Beck S, Fühlhuber V, et al.: New autoantibodies in pediatric opsoclonus myoclonus syndrome. Ann N Y Acad Sci 2007, 1110:256-260.
25. Wong A: An update on opsoclonus. Curr Opin Neurol 2007, 20:25-31.
26. Kumar A, Lajara-Nanson WA, Neilson RW Jr: Paraneoplastic opsoclonus-myoclonus syndrome: Initial presentation of non-Hodgkins lymphoma. J Neurooncol 2005,73: 43-45.
27. Bataller L, Graus F, Saiz A, et al.: Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 2001, 124:437-443.
28. Gabaldon-Torres L, Fernandez-Dominguez J, Salas-Felipe J, et al.: Opsoclonus-myoclonus-ataxia syndrome: Two anatomoclinical case reports. Rev Neurol 2009, 48:137-140.
29. Fitzpatrick AS, Gray OM, McConville J, McDonnell GV: Opsoclonus-myoclonus syndrome associated with benign ovarian teratoma. Neurology 2008, 70:1292-1293.
30. Jung KY, Youn J, Chung CS: Opsoclonus-myoclonus syndrome in an adult with malignant melanoma. J Neurol 2006, 253:942-943.
31. Van Diest D, De Raeve H, Claes J, et al.: Paraneoplastic opsoclonus-myoclonus-ataxia (OMA) syndrome in an adult patient with esthesioneuroblastoma. J Neurol 2008, 255:594-596.
32. Straube A, Leigh RJ, Bronstein A, et al.: EFNS task force-therapy of nystagmus and oscillopsia. Eur J Neurol 2004, 11:83-89.
33. Vernino S, Tuite P, Adler CH, et al.: Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol 2002, 51: 625-630.
34. Krolak-Salmon P, Androdias G, Meyronet D, et al.: Slow evolution of cerebellar degeneration and chorea in a man with anti-Yo antibodies. Eur J Neurol 2006, 13:307-308.
35. Kinirons P, Fulton A, Keoghan M, et al.: Paraneoplastic limbic encephalitis (PLE) and chorea associated with CRMP-5 neuronal antibody. Neurology 2003, 61:1623-1624.
36. Yu Z, Kryzer TJ, Griesmann GE, et al.: CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001, 49:146-154.
37. Nuti A, Ceravolo R, Salvetti S, et al.: Paraneoplastic choreic syndrome during non-Hodgkin's lymphoma. Mov Disord 2000, 15:350-352.
38. Kellinghaus C, Kraus J, Blaes F, et al.: CRMP-5-autoantibodies in testicular cancer associated with limbic encephalitis and choreiform dyskinesias. Eur Neurol 2007, 57:241-243.
39. Kujawa KA, Niemi VR, Tomasi MA, et al.: Ballistic-choreic movements as the presenting feature of renal cancer. Arch Neurol 2001, 58:1133-1135.
40. Dorban S, Gille M, Kessler R, et al.: Chorea-athetosis in the anti-Hu syndrome. Rev Neurol (Paris) 2004, 160:126-129.
41. Tremont-Lukats IW, Fuller GN, Ribalta T, et al.: Paraneoplastic chorea: case study with autopsy confirmation. Neuro Oncol 2002, 4:192-195.
42. Golbe LI, Miller DC, Duvoisin RC: Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism. Mov Disord 1989, 4: 147-152.
43. Mousa AR, Al-Din AN: Neurological and cardiac complications of carcinoma of the breast. Case report. Acta Neurol Scand 1985, 72:518-521.
44. Fahn S, Rrin MF, Dwork AJ, et al.: Case 1, 1996: rapidly progressive parkinsonism, incontinence, impotency, and levodopa-induced moaning in a patient with multiple myeloma. Mov Disord 1996, 11:298-310.
45. Tan JH, Goh BC, Tambyah PA, Wilder-Smith E: Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma. Parkinsonism Relat Disord 2005, 11:187-191.
46. Jankovic J: Progressive suPranuclear palsy: paraneoplastic effect of bronchial carcinoma. Neurology 1985, 35:446-447.
47. Valentino P, Labate A, Pirritano D, et al.: Orolingual tremor as unusual presentation of anti-Hu paraneoplastic syndrome. Mov Disord 2008, 23:1791-1792.
48. Gilhuis HJ, van Ommen HJ, Pannekoek BJ, et al.: Paraneoplastic orthostatic tremor associated with small cell lung cancer. Eur Neurol 2005, 54:225-226.
49. Simonetti F, Pergami P, Aktipi KM, et al.: Paraneoplastic "rubral" tremor: A case report. Mov Disord 1998, 13:612-614.
50. Dalmau J, Gleichman AJ, Hughes EG, et al.: Anti-NMDAreceptor encephalitis: Case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7:1091-1098.
51. Eker A, Saka E, Dalmau J, et al.: Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis. J Neurol Neurosurg Psychiatry 2008, 79:1082-1083.